FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309368997> ?p ?o ?g. }

• W4309368997 endingPage "16203" @default.
• W4309368997 startingPage "16173" @default.
• W4309368997 abstract "Rapid emergence of tumor resistance via RAS pathway reactivation has been reported from clinical studies of covalent KRASG12C inhibitors. Thus, inhibitors with broad potential for combination treatment and distinct binding modes to overcome resistance mutations may prove beneficial. JDQ443 is an investigational covalent KRASG12C inhibitor derived from structure-based drug design followed by extensive optimization of two dissimilar prototypes. JDQ443 is a stable atropisomer containing a unique 5-methylpyrazole core and a spiro-azetidine linker designed to position the electrophilic acrylamide for optimal engagement with KRASG12C C12. A substituted indazole at pyrazole position 3 results in novel interactions with the binding pocket that do not involve residue H95. JDQ443 showed PK/PD activity in vivo and dose-dependent antitumor activity in mouse xenograft models. JDQ443 is now in clinical development, with encouraging early phase data reported from an ongoing Phase Ib/II clinical trial (NCT04699188)." @default.
• W4309368997 created "2022-11-26" @default.
• W4309368997 creator A5000652554 @default.
• W4309368997 creator A5004306360 @default.
• W4309368997 creator A5004338973 @default.
• W4309368997 creator A5005029428 @default.
• W4309368997 creator A5014099042 @default.
• W4309368997 creator A5014519705 @default.
• W4309368997 creator A5016851495 @default.
• W4309368997 creator A5022015250 @default.
• W4309368997 creator A5026557511 @default.
• W4309368997 creator A5029740335 @default.
• W4309368997 creator A5030906053 @default.
• W4309368997 creator A5038966466 @default.
• W4309368997 creator A5045824325 @default.
• W4309368997 creator A5048481491 @default.
• W4309368997 creator A5050799087 @default.
• W4309368997 creator A5053646331 @default.
• W4309368997 creator A5061261743 @default.
• W4309368997 creator A5061293560 @default.
• W4309368997 creator A5061629566 @default.
• W4309368997 creator A5064810879 @default.
• W4309368997 creator A5064974711 @default.
• W4309368997 creator A5065994986 @default.
• W4309368997 creator A5066345471 @default.
• W4309368997 creator A5071619134 @default.
• W4309368997 creator A5074419345 @default.
• W4309368997 creator A5075262595 @default.
• W4309368997 creator A5076904265 @default.
• W4309368997 creator A5077688221 @default.
• W4309368997 creator A5084362654 @default.
• W4309368997 creator A5086893977 @default.
• W4309368997 creator A5088972251 @default.
• W4309368997 date "2022-11-18" @default.
• W4309368997 modified "2023-10-14" @default.
• W4309368997 title "JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS^G12C for the Treatment of Solid Tumors" @default.
• W4309368997 cites W1963826141 @default.
• W4309368997 cites W2004774286 @default.
• W4309368997 cites W2058616449 @default.
• W4309368997 cites W2114163388 @default.
• W4309368997 cites W2124026197 @default.
• W4309368997 cites W2128339707 @default.
• W4309368997 cites W2134917212 @default.
• W4309368997 cites W2138863392 @default.
• W4309368997 cites W2143660875 @default.
• W4309368997 cites W2163341755 @default.
• W4309368997 cites W2287686703 @default.
• W4309368997 cites W2331069654 @default.
• W4309368997 cites W2732767128 @default.
• W4309368997 cites W2771729549 @default.
• W4309368997 cites W2982321167 @default.
• W4309368997 cites W2982602983 @default.
• W4309368997 cites W2999810289 @default.
• W4309368997 cites W3014882016 @default.
• W4309368997 cites W3058018199 @default.
• W4309368997 cites W3087229737 @default.
• W4309368997 cites W3142010099 @default.
• W4309368997 cites W3157480760 @default.
• W4309368997 cites W3172081492 @default.
• W4309368997 cites W3192061663 @default.
• W4309368997 cites W3208053409 @default.
• W4309368997 cites W3212888956 @default.
• W4309368997 cites W3215936267 @default.
• W4309368997 cites W4214569871 @default.
• W4309368997 cites W4223470164 @default.
• W4309368997 cites W4224258248 @default.
• W4309368997 cites W4224996144 @default.
• W4309368997 cites W4226075561 @default.
• W4309368997 cites W4231423004 @default.
• W4309368997 cites W4281650778 @default.
• W4309368997 cites W4282916816 @default.
• W4309368997 cites W4282972221 @default.
• W4309368997 doi "https://doi.org/10.1021/acs.jmedchem.2c01438" @default.
• W4309368997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36399068" @default.
• W4309368997 hasPublicationYear "2022" @default.
• W4309368997 type Work @default.
• W4309368997 citedByCount "14" @default.
• W4309368997 countsByYear W43093689972023 @default.
• W4309368997 crossrefType "journal-article" @default.
• W4309368997 hasAuthorship W4309368997A5000652554 @default.
• W4309368997 hasAuthorship W4309368997A5004306360 @default.
• W4309368997 hasAuthorship W4309368997A5004338973 @default.
• W4309368997 hasAuthorship W4309368997A5005029428 @default.
• W4309368997 hasAuthorship W4309368997A5014099042 @default.
• W4309368997 hasAuthorship W4309368997A5014519705 @default.
• W4309368997 hasAuthorship W4309368997A5016851495 @default.
• W4309368997 hasAuthorship W4309368997A5022015250 @default.
• W4309368997 hasAuthorship W4309368997A5026557511 @default.
• W4309368997 hasAuthorship W4309368997A5029740335 @default.
• W4309368997 hasAuthorship W4309368997A5030906053 @default.
• W4309368997 hasAuthorship W4309368997A5038966466 @default.
• W4309368997 hasAuthorship W4309368997A5045824325 @default.
• W4309368997 hasAuthorship W4309368997A5048481491 @default.
• W4309368997 hasAuthorship W4309368997A5050799087 @default.
• W4309368997 hasAuthorship W4309368997A5053646331 @default.
• W4309368997 hasAuthorship W4309368997A5061261743 @default.
• W4309368997 hasAuthorship W4309368997A5061293560 @default.
• W4309368997 hasAuthorship W4309368997A5061629566 @default.

• next